查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1937032

全球动物肠道健康市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Animal Intestinal Health Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 177 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

动物肠道健康市场规模预计将从 2025 年的 46.5 亿美元成长到 2034 年的 85.9 亿美元，2026 年至 2034 年的复合年增长率为 7.06%。

受人们对农场动物和伴侣动物肠道健康重要性认识不断提高的推动，动物肠道健康市场预计将迎来显着增长。随着全球对动物性蛋白质需求的成长，生产商正致力于优化动物健康和生产力，以确保永续生产。人们普遍认识到肠道健康在促进营养吸收、增强免疫力和降低疾病易感性方面的重要作用，这导致对促进肠道健康的产品需求激增。

益生菌、益生元和其他肠道健康补充剂的创新是推动市场扩张的关键因素。这些产品不仅有助于消化系统健康，还有助于改善动物的整体健康状况，这在竞争激烈的农业环境中至关重要。随着生产者寻求最大限度地减少抗生素和其他合成添加剂的使用，天然和有机农业的趋势日益增长，这进一步推动了对符合这些原则的肠道健康解决方案的需求。

此外，通用感染疾病率的上升以及消费者对安全优质动物产品日益增长的需求，正促使生产商加大对动物健康解决方案的投资。监管压力和满足食品安全标准的需求也是推动市场发展的关键因素。随着更多研究揭示肠道环境与动物整体表现之间错综复杂的关係，动物肠道健康市场预计将迎来强劲成长，尤其关注能够满足不同类型动物独特需求的创新解决方案。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 绘製渗透率和成长前景图
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

4. 全球动物肠道健康市场（依产品类型划分）

  • 市场分析、洞察与预测
  • 益生菌
  • 益生元
  • 植物源
  • 酵素
  • 有机酸
  • 其他的

5. 全球动物肠道健康市场（依动物类型划分）

  • 市场分析、洞察与预测
  • 家禽
  • 猪
  • 反刍动物
  • 水产养殖
  • 宠物
  • 其他的

6. 全球动物肠道健康市场（以剂型划分）

  • 市场分析、洞察与预测
  • 干燥
  • 液体

7. 全球动物肠道健康市场（依分销管道划分）

  • 市场分析、洞察与预测
  • 兽医诊所
  • 零售店
  • 网路商店
  • 其他的

8. 全球动物肠道健康市场（依地区划分）

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第九章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商格局（基于现有资讯）
  • 策略规划

第十章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Chr. Hansen Holding A/S
    • Koninklijke DSM NV
    • DuPont De Nemours Inc
    • Novozymes A/S
    • Evonik Industries AG
    • Basf Se
    • Kemin Industries Inc
    • Cargill Incorporated
    • Archer Daniels Midland Company
    • Bluestar Adisseo Company
    • Nutreco NV
    • Alltech Inc
    • Novus International Inc
    • Biomin Holding GmbH
    • Lallemand Inc
简介目录
Product Code: VMR11214634

The Animal Intestinal Health Market size is expected to reach USD 8.59 Billion in 2034 from USD 4.65 Billion (2025) growing at a CAGR of 7.06% during 2026-2034.

The animal intestinal health market is poised for significant growth, driven by the increasing awareness of the importance of gut health in livestock and companion animals. As the global demand for animal protein rises, producers are increasingly focusing on optimizing animal health and performance to ensure sustainable production. The role of gut health in enhancing nutrient absorption, improving immunity, and reducing disease susceptibility is becoming more recognized, leading to a surge in demand for products that promote intestinal health.

Innovations in probiotics, prebiotics, and other gut health supplements are at the forefront of this market expansion. These products not only support digestive health but also contribute to overall animal well-being, which is critical in a competitive agricultural landscape. The growing trend towards natural and organic farming practices is further driving the demand for gut health solutions that align with these principles, as producers seek to minimize the use of antibiotics and other synthetic additives.

Moreover, the increasing incidence of zoonotic diseases and the rising consumer demand for safe, high-quality animal products are compelling producers to invest in animal health solutions. Regulatory pressures and the need for compliance with food safety standards are also significant factors driving the market. As research continues to unveil the intricate relationship between gut health and overall animal performance, the animal intestinal health market is expected to witness robust growth, with a focus on innovative solutions that cater to the specific needs of different animal species.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Probiotics
  • Prebiotics
  • Phytogenics
  • Enzymes
  • Organic Acids
  • Others

By Animal Type

  • Poultry
  • Swine
  • Ruminants
  • Aquaculture
  • Pets
  • Others

By Form

  • Dry
  • Liquid

By Distribution Channel

  • Veterinary Clinics
  • Retail Stores
  • Online Stores
  • Others

COMPANIES PROFILED

  • Chr Hansen Holding AS, Koninklijke DSM NV, DuPont de Nemours Inc, Novozymes AS, Evonik Industries AG, Basf Se, Kemin Industries Inc, Cargill Incorporated, Archer Daniels Midland Company, Bluestar Adisseo Company, Nutreco NV, Alltech Inc, Novus International Inc, Biomin Holding GmbH, Lallemand Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Probiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Prebiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Phytogenics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Organic Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Animal Type
  • 5.2. Poultry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Swine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Ruminants Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Aquaculture Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Pets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET: BY FORM 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Form
  • 6.2. Dry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Liquid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Distribution Channel
  • 7.2. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Retail Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Online Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Animal Type
    • 8.2.3 By Form
    • 8.2.4 By Distribution Channel
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Animal Type
    • 8.3.3 By Form
    • 8.3.4 By Distribution Channel
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Animal Type
    • 8.4.3 By Form
    • 8.4.4 By Distribution Channel
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Animal Type
    • 8.5.3 By Form
    • 8.5.4 By Distribution Channel
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Animal Type
    • 8.6.3 By Form
    • 8.6.4 By Distribution Channel
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ANIMAL INTESTINAL HEALTH INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Chr. Hansen Holding A/S
    • 10.2.2 Koninklijke DSM N.V
    • 10.2.3 DuPont De Nemours Inc
    • 10.2.4 Novozymes A/S
    • 10.2.5 Evonik Industries AG
    • 10.2.6 Basf Se
    • 10.2.7 Kemin Industries Inc
    • 10.2.8 Cargill Incorporated
    • 10.2.9 Archer Daniels Midland Company
    • 10.2.10 Bluestar Adisseo Company
    • 10.2.11 Nutreco N.V
    • 10.2.12 Alltech Inc
    • 10.2.13 Novus International Inc
    • 10.2.14 Biomin Holding GmbH
    • 10.2.15 Lallemand Inc